Profound Medical (PROF) Net Income towards Common Stockholders (QoQ) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Profound Medical | 244.28 Mn | 193.99 Mn | 3.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -90.84% |
| Dec 31, 2025 | 1,064.84% |
| Sep 30, 2025 | 49.17% |
| Jun 30, 2025 | -246.35% |
| Mar 31, 2025 | -78.84% |
| Dec 31, 2024 | 641.22% |
| Sep 30, 2024 | -35.35% |
| Jun 30, 2024 | -5.07% |
| Mar 31, 2024 | 86.46% |
| Dec 31, 2023 | -979.56% |
| Sep 30, 2023 | -24.12% |
| Jun 30, 2023 | 9.63% |
| Mar 31, 2023 | 114.01% |
| Dec 31, 2022 | -1,055.93% |
| Sep 30, 2022 | -16.08% |
| Jun 30, 2022 | -27.74% |
| Mar 31, 2022 | 116.05% |
| Dec 31, 2021 | -957.94% |
| Sep 30, 2021 | -14.92% |
| Jun 30, 2021 | -6.50% |
| Sep 30, 2020 | 14.78% |
| Jun 30, 2020 | 98.57% |
| Mar 31, 2020 | -82.76% |
| Dec 31, 2019 | 219.37% |
| Sep 30, 2019 | 8.44% |
| Jun 30, 2019 | 100.10% |